Dr. Brian E. Jahns is an accomplished business leader with robust and progressive experience in the biopharmaceutical industry.
Brian joined Trillium Therapeutics Inc. in 2017 as Senior Vice-President, Commercial and Business Development. Trillium Therapeutics Inc. is a clinical stage immune-oncology company developing innovative small molecules and biologic therapies for the treatment of cancer. In this role, Brian is responsible for providing commercial direction into the clinical and regulatory strategy, as well as executing business development activities.
Prior to working for Trillium Therapeutics, Brian worked at Hoffmann-La Roche Canada. Joining the organization in 1998, he fulfilled various medical, marketing, and sales leadership roles where he was deeply involved in the successful launch and growth of several antiviral agents, transplant immunosuppressants and anticancer biologics. He grew a keen interest in all factors influencing optimized patient care, including the promise of personalized medicine, the intricacies of how medicines are used and the connection between funding and the ability to improve outcomes. Brian rose to become Vice President of Oncology Marketing and Sales, and then Vice President of Product Strategy at Roche Canada. There, he provided the strategic framework that allowed brands to exceed expectations, and he exemplified a key quality of a great leader – the ability to connect with others, and inspire them to greatness.
In an era that embraces innovation and patient centricity, Brian’s perspective is shaped by his experiences as a healthcare provider, researcher and marketer. Whether it is his ability to help others reach their professional potential or to help patients affected by rare diseases, Brian is a change agent who is not only in step with the growth of biopharmaceuticals - he is helping to drive it, to ensure that patients benefit.